NVDA | Nvidia Corp

CUSIP: 67066G104

8 Funds Holding

23.2M Total Shares

$4.6B Total Value

$227.98
Price

$5.51T

Market Cap

32.2

P/E Ratio

15.7

Forward P/E

$7.09

EPS (TTM)

0.47%

Dividend Yield

$53.2B

Cash

$11.0B

Total Debt

24.15B

Shares Out

$164.07

$236.54

52-Week Range

Fund / Manager Click to search	Shares	Value	% of Portfolio	Cost Basis	Est. Return
Tiger Global Management\|Chase Coleman	11.2M	$2.2B	9.34%	$74.54	+205.84%
H&H International Investment\|Duan Yongping	6.3M	$1.3B	6.58%	$182.51	+24.92%
Egerton Capital\|John Armitage	3.4M	$684M	6.61%	$189.77	+20.13%
Appaloosa Management\|David Tepper	1.5M	$305M	3.95%	$149.03	+52.98%
Patient Capital Management\|Samantha McLemore	709.6K	$142M	4.65%	$86.76	+162.77%
Tsai Capital\|Christopher Tsai	35.3K	$7M	5.22%	$160.35	+42.18%
Oakmark Select Fund\|Bill Nygren	12.5K	$2M	0.00%	—	—
Causeway Capital Management\|Sarah Ketterer	3.6K	$713721	0.01%	$102.61	+118.84%

Quarter:

Fund / Manager Click to search	Action	Change	Shares After	Value	Price
2026-Q2
H&H International Investment	SELL	-54.6%	6.3M	$1.3B	$207.41
Tiger Global Management	SELL	-6.8%	11.2M	$2.2B	$207.41
Egerton Capital	BUY	+27.8%	3.4M	$684M	$207.41
Appaloosa Management	BUY	+3.6%	1.5M	$305M	$207.41
Patient Capital Management	SELL	-0.2%	709.6K	$142M	$207.41
Third Point LLC	SELL	EXIT	—	—	$207.41
Tsai Capital	BUY	+40.3%	35.3K	$7M	$207.41
Causeway Capital Management	SELL	-0.6%	3.6K	$713721	$207.41
2026-Q1
H&H International Investment	BUY	+91.3%	13.8M	$2.4B	$184.88
Tiger Global Management	BUY	+9.1%	12.0M	$2.1B	$184.88
Third Point LLC	SELL	-93.6%	190.0K	$33M	$184.88
Egerton Capital	BUY	NEW	2.7M	$467M	$184.88
Appaloosa Management	SELL	-13.4%	1.5M	$257M	$184.88
Patient Capital Management	BUY	+11.3%	711.1K	$124M	$184.88
Tsai Capital	BUY	+2.6%	25.2K	$4M	$184.88
Causeway Capital Management	SELL	-4.5%	3.6K	$625922	$184.88
Kahn Brothers Group	SELL	EXIT	—	—	$184.88
2025-Q4
Tiger Global Management	SELL	-6.0%	11.0M	$2.1B	$185.04
H&H International Investment	BUY	NEW	7.2M	$1.3B	$185.04
Third Point LLC	BUY	+3.5%	3.0M	$550M	$185.04
Appaloosa Management	SELL	-10.5%	1.7M	$317M	$185.04
Patient Capital Management	BUY	+1.0%	638.8K	$119M	$185.04
Tsai Capital	SELL	-2.2%	24.5K	$5M	$185.04
Causeway Capital Management	SELL	-1.2%	3.8K	$700867	$185.04
2025-Q3
Third Point LLC	BUY	+1.8%	2.9M	$532M	$175.64
Appaloosa Management	BUY	+8.6%	1.9M	$355M	$175.64
H&H International Investment	SELL	-38.0%	597.8K	$112M	$175.64
Patient Capital Management	SELL	-0.2%	632.7K	$118M	$175.64
Tsai Capital	BUY	+38.5%	25.1K	$5M	$175.64
Causeway Capital Management	BUY	+4.8%	3.8K	$709937	$175.64
Kahn Brothers Group	BUY	NEW	1.7K	$324784	$175.64
2025-Q2
Tiger Global Management	BUY	+6.8%	11.7M	$1.9B	$131.29
Third Point LLC	BUY	+93.1%	2.8M	$442M	$131.29
Appaloosa Management	BUY	+483.3%	1.8M	$276M	$131.29
H&H International Investment	BUY	+49.6%	964.8K	$152M	$131.29
Patient Capital Management	BUY	+1.1%	634.2K	$100M	$131.29
Tsai Capital	SELL	-0.1%	18.1K	$3M	$131.29
Causeway Capital Management	SELL	-11.9%	3.6K	$573662	$131.29
2025-Q1
Tiger Global Management	BUY	+13.3%	11.0M	$1.2B	$126.63
Third Point LLC	BUY	NEW	1.4M	$157M	$126.63
Appaloosa Management	SELL	-55.9%	300.0K	$33M	$126.63
Patient Capital Management	BUY	+3.0%	627.0K	$68M	$126.63
H&H International Investment	BUY	NEW	645.1K	$70M	$126.63
Tsai Capital	BUY	NEW	18.1K	$2M	$126.63
Causeway Capital Management	BUY	+7.4%	4.1K	$446959	$126.63
2024-Q4
Appaloosa Management	BUY	+8.8%	680.0K	$91M	$138.63
Patient Capital Management	SELL	-0.0%	608.6K	$82M	$138.63
Causeway Capital Management	SELL	-9.3%	3.8K	$515674	$138.63
2024-Q3
Appaloosa Management	SELL	-9.4%	625.0K	$76M	$118.08
Patient Capital Management	BUY	+0.5%	608.7K	$74M	$118.08
Causeway Capital Management	BUY	+33.5%	4.2K	$514056	$118.08
2024-Q2
Tiger Global Management	BUY	+900.0%	9.7M	$1.2B	$92.14
Appaloosa Management	BUY	+56.1%	690.0K	$85M	$92.14
Patient Capital Management	SELL	-0.0%	605.8K	$75M	$92.14
Causeway Capital Management	SELL	-5.1%	3.2K	$391622	$92.14
2024-Q1
Appaloosa Management	SELL	-44.0%	442.0K	$399M	$721.33
Patient Capital Management	BUY	NEW	60.6K	$55M	$721.33
Causeway Capital Management	BUY	NEW	334	$301789	$721.33
2023-Q4
Tiger Global Management	SELL	-12.9%	968.4K	$480M	$467.65
Appaloosa Management	SELL	-22.9%	790.0K	$391M	$467.65
Gates Foundation Trust	SELL	EXIT	—	—	$467.65
2023-Q3
Tiger Global Management	BUY	+76.8%	1.1M	$483M	$446.80
Appaloosa Management	BUY	+0.5%	1.0M	$446M	$446.80
Lone Pine Capital	SELL	EXIT	—	—	$446.80
Third Point LLC	SELL	EXIT	—	—	$446.80
Gates Foundation Trust	BUY	NEW	9.2K	$4M	$446.80
2023-Q2
Appaloosa Management	BUY	+580.0%	1.0M	$431M	$292.13
Lone Pine Capital	BUY	NEW	641.6K	$271M	$292.13
Tiger Global Management	BUY	NEW	628.6K	$266M	$292.13
Third Point LLC	BUY	NEW	500.0K	$212M	$292.13
2023-Q1
Appaloosa Management	BUY	NEW	150.0K	$42M	$221.73
Tiger Global Management	BUY	NEW	43.9K	$12M	$221.73
2020-Q3
Wedgewood Partners	SELL	EXIT	—	—	$462.56
2020-Q2
Wedgewood Partners	SELL	-51.0%	40.8K	$16M	$331.05
2020-Q1
Wedgewood Partners	SELL	-53.0%	83.3K	$22M	$249.28
2019-Q4
Wedgewood Partners	BUY	+25.5%	177.1K	$42M	$208.57
2019-Q3
Wedgewood Partners	BUY	NEW	141.1K	$25M	$168.44
2018-Q4
Lone Pine Capital	SELL	EXIT	—	—	$197.74
2018-Q3
Lone Pine Capital	BUY	+4.7%	2.2M	$628M	$256.95
2018-Q2
Lone Pine Capital	BUY	NEW	2.1M	$506M	$244.90
Appaloosa Management	SELL	EXIT	—	—	$244.90
2018-Q1
Appaloosa Management	BUY	NEW	150.0K	$35M	$236.54

No Insider Transactions

No Form 4 filings found for this stock in the last 2 years.